E, M., L, D. R., E, D., E, D., T, D. B., P, V. N., . . . S, H. (2025). SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021. Vaccine, 51, 126865. https://doi.org/10.1016/j.vaccine.2025.126865
Chicago Style (17th ed.) CitationE, Meyers, et al. "SARS-CoV-2 Seroreversion and All-cause Mortality in Nursing Home Residents and Staff Post-primary Course Vaccination in Belgium Between February and December 2021." Vaccine 51 (2025): 126865. https://doi.org/10.1016/j.vaccine.2025.126865.
MLA (9th ed.) CitationE, Meyers, et al. "SARS-CoV-2 Seroreversion and All-cause Mortality in Nursing Home Residents and Staff Post-primary Course Vaccination in Belgium Between February and December 2021." Vaccine, vol. 51, 2025, p. 126865, https://doi.org/10.1016/j.vaccine.2025.126865.